Among adults who reported having used a GLP-1 or GLP-1/GIP medication for weight loss in the past year (at all, and exclusively for weight loss), we estimated the proportion who used a medication licensed for weight loss in Great Britain (Saxenda, Wegovy, or Mounjaro)
Future randomized trials should evaluate iron indices, hepcidin levels, ferritin, transferrin saturation, and hemoglobin trends in patients treated with GLP-1 receptor agonists
The medication's effect on gastric emptying can lead to feelings of fullness, bloating, and discomfort, which may be difficult to distinguish from IBS symptoms
But Im good and glad Ive tried this medicine
Um, one, I think there's a misunderstanding that this is a [00:39:00] scientifically founded in humans risk because there has never been an incidence of thyroid cancer caused by a GLP one